Renewal window: 12 September 2033 to 12 September 2034 (+6 months grace at a higher fee).
Trademark details
| Mark | ONCOLYTIC IMMUNOTH ERAPY |
|---|---|
| Application number | 431393 |
| Registration number | 431393 |
| Class | Class 5 Pharmaceuticals & medical preparations |
| Status | Registered |
| Filing date | 12 September 2024 |
| Published | 17 December 2024 · Bulletin No. 308 |
| Registered | 4 February 2025 |
| Expires / renewal due | 12 September 2034 |
About this trademark
“ONCOLYTIC IMMUNOTH ERAPY” is a trademark on the UAE register, filed on 12 September 2024 under application number 431393.
It covers Class 5 (Pharmaceuticals & medical preparations).
It was accepted and published in the UAE Trademark Bulletin No. 308 on 17 December 2024.
It was registered on 4 February 2025.
The registration runs until 12 September 2034 — 10 years from filing — and can be renewed in the last year before that date.
Goods and services
As filed with the Ministry of Economy and Tourism (in Arabic). Protection covers only what is listed.
Mark description: تتكون العلامة من الكلمات " ONCOLYTIC IMMUNOTHERAPY " كتبت بحروف لاتينية باللون الأسود. والعلامة ككل .باللونين الأسود والأبيض
Gazette history
Similar UAE trademarks
Similar by name. See all similar marks · Check your own name
Explore
Class 5 explainedClass 5 marks open for opposition Status check
Source: UAE Trademark Bulletin (Ministry of Economy and Tourism) as read by TrademarksHub; renewal date worked out from the filing date. Trademark data only — owner details are not published on this site. Check the official register before acting. Not legal advice.